(Q48892080)

16 February 2018

title

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534177

6 October 2022

1 reference

D. E. Casey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1534177

6 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1534177

6 October 2022

publication date

1 January 1992

1 reference

16 February 2018

published in

Psychopharmacology

1 reference

16 February 2018

volume

107

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

page(s)

18-22

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02244960

exact match

0 references

cites work

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02244960

Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems

21 January 2018

1 reference

12 December 2020

SCH 23390 and psychosis

1 reference

12 December 2020

Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates

1 reference

12 December 2020

Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors

1 reference

12 December 2020

Effect of selective D1 and D2 dopamine receptor antagonists and agonists in Cebus monkeys: implications for acute and tardive dyskinesias. A preliminary report

1 reference

12 December 2020

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride

1 reference

12 December 2020

The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment

1 reference

12 December 2020

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

12 December 2020

Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia

1 reference

12 December 2020

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

12 December 2020

Dopamine, acetylcholine, and GABA effects in acute dystonia in primates

1 reference

12 December 2020

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

12 December 2020

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1 reference

12 December 2020

Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

1 reference

12 December 2020

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Extrapyramidal syndromes in nonhuman primates: typical and atypical neuroleptics

1 reference

12 December 2020

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244960

1 reference

16 February 2018

1 reference

16 February 2018